The Impact of Social Roles on the Experience of Men in BRCA1/2 Families: Implications for Counseling

Overview

Journal J Genet Couns

Publisher Wiley

Specialty Genetics

Date 2008 Aug 9

PMID 18688698

Citations 18

Authors

Mary B Daly

Affiliations

Soon will be listed here.

Abstract

Recent advances in genetics have identified several genes associated with inherited susceptibility to breast and ovarian cancer and have led to the commercial availability of mutation analyses. Although the majority of cancers associated with BRCA1/2 mutations are seen in women, men with BRCA1/2 mutations are at increased risk for male breast cancer, prostate cancer, pancreatic cancer and melanoma. Limited data available on the response of men in BRCA1/2 families suggest that the majority do not pursue genetic counseling, thus they may forgo the opportunity to improve health practices and to pass on valuable cancer risk information to offspring. The patterns of relationships of men within the family and society can pose challenges to their recognition of genetic health threats and the need for preventive interventions. Genetic counselors are in a position to inform at-risk males of their genetic risk, and to help them explore their personal health options.

Citing Articles

The multigenerational impact of long QT syndrome: A Gitxsan perspective.

Huisman L, Martin S, Ewasiuk E, McAdam A, Wood Lynes-Ford K, McCormick R J Genet Couns. 2024; 34(1):e1927.

PMID: 38926912 PMC: 11735187. DOI: 10.1002/jgc4.1927.

The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral center.

Scharnitz T, Nakamura M, Koeppe E, Henry M, Lowe L, Else T Am J Cancer Res. 2023; 13(1):236-244.

PMID: 36777509 PMC: 9906083.

Psychological Determinants of Men's Adherence to Cascade Screening for .

Ongaro G, Petrocchi S, Calvello M, Bonanni B, Feroce I, Pravettoni G Curr Oncol. 2022; 29(4):2490-2503.

PMID: 35448177 PMC: 9030516. DOI: 10.3390/curroncol29040203.

Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.

Annoni A, Longhini C PLoS One. 2022; 17(3):e0265387.

PMID: 35303741 PMC: 8932559. DOI: 10.1371/journal.pone.0265387.

Parent of Origin Effects on Family Communication of Risk in + Women: A Qualitative Investigation of Human Factors in Cascade Screening.

Dwyer A, Hesse-Biber S, Flynn B, Remick S Cancers (Basel). 2020; 12(8).

PMID: 32824510 PMC: 7464326. DOI: 10.3390/cancers12082316.

References

Liede A, Karlan B, Narod S . Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. J Clin Oncol. 2004; 22(4):735-42. DOI: 10.1200/JCO.2004.05.055. View

Pfeffer N, McCarthy Veach P, LeRoy B . An investigation of genetic counselors' discussion of genetic discrimination with cancer risk patients. J Genet Couns. 2004; 12(5):419-38. DOI: 10.1023/a:1025816820243. View

Klitzman R, Thorne D, Williamson J, Chung W, Marder K . Disclosures of Huntington disease risk within families: patterns of decision-making and implications. Am J Med Genet A. 2007; 143A(16):1835-49. DOI: 10.1002/ajmg.a.31864. View

King M, Rowell S, Love S . Inherited breast and ovarian cancer. What are the risks? What are the choices?. JAMA. 1993; 269(15):1975-80. View

Dube C, Fuller B . A qualitative study of communication skills for male cancer screening discussions. J Cancer Educ. 2004; 18(4):182-7. DOI: 10.1207/s15430154jce1804_4. View

Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L . Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev. 1999; 8(4 Pt 2):329-36. View

Finlay E, Stopfer J, Burlingame E, Evans K, Nathanson K, Weber B . Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genet Test. 2008; 12(1):81-91. PMC: 3072893. DOI: 10.1089/gte.2007.0037. View

van Oostrom I, Meijers-Heijboer H, Duivenvoorden H, Brocker-Vriends A, van Asperen C, Sijmons R . Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet. 2007; 71(1):35-42. DOI: 10.1111/j.1399-0004.2007.00731.x. View

Gayther S, Mangion J, Russell P, Seal S, Barfoot R, Ponder B . Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet. 1997; 15(1):103-5. DOI: 10.1038/ng0197-103. View

10.

Hallowell N, Arden-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C . Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociol Health Illn. 2006; 28(7):969-88. DOI: 10.1111/j.1467-9566.2006.00515.x. View

11.

Courtenay W . Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Soc Sci Med. 2000; 50(10):1385-401. DOI: 10.1016/s0277-9536(99)00390-1. View

12.

Patenaude A, Dorval M, DiGianni L, Schneider K, Chittenden A, Garber J . Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol. 2006; 24(4):700-6. DOI: 10.1200/JCO.2005.01.7541. View

13.

Gough B . Try to be healthy, but don't forgo your masculinity: deconstructing men's health discourse in the media. Soc Sci Med. 2006; 63(9):2476-88. DOI: 10.1016/j.socscimed.2006.06.004. View

14.

Hadley D, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr D . Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med. 2003; 163(5):573-82. DOI: 10.1001/archinte.163.5.573. View

15.

Horsburgh S, Matthew A, Bristow R, Trachtenberg J . Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic. Prostate. 2005; 65(2):124-9. DOI: 10.1002/pros.20278. View

16.

Beery T, Williams J . Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genet Test. 2007; 11(2):111-23. DOI: 10.1089/gte.2006.0527. View

17.

Brooks G . Masculinity and men's mental health. J Am Coll Health. 2001; 49(6):285-97. DOI: 10.1080/07448480109596315. View

18.

Hallowell N, Ardern-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C . Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet. 2005; 67(6):492-502. DOI: 10.1111/j.1399-0004.2005.00443.x. View

19.

Edwards S, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P . Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet. 2002; 72(1):1-12. PMC: 420008. DOI: 10.1086/345310. View

20.

Hagoel L, Dishon S, Almog R, Silman Z, Rennert G . Proband family uptake of familial-genetic counselling. Psychooncology. 2001; 9(6):522-7. DOI: 10.1002/1099-1611(200011/12)9:6<522::aid-pon492>3.0.co;2-s. View